CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Pazopanib for the Treatment of Non-clear Cell Renal Cell Carcinoma: A Single-Arm, Open-Label, Multicenter, Phase II Study

Ki Sun Jung, Su Jin Lee, Se Hoon Park, Jae-Lyun Lee, Se-Hoon Lee, Jae Yun Lim, Jung Hun Kang, Suee Lee, Sun Young Rha, Kyung Hee Lee, Ho Young Kim, Ho Yeong Lim

Cancer Research and Treatment. 2018;50(2):488-494. Published online 2017 May 22 DOI: https://doi.org/10.4143/crt.2016.584

Pazopanib for the Treatment of Non-clear Cell Renal Cell Carcinoma: A Single-Arm, Open-Label, Multicenter, Phase II Study

Ki Sun Jung, Su Jin Lee, Se Hoon Park, Jae-Lyun Lee, Se-Hoon Lee, Jae Yun Lim, Jung Hun Kang, Suee Lee, Sun Young Rha, Kyung Hee Lee, Ho Young Kim, Ho Yeong Lim

Cancer Research and Treatment. 2018;50(2):488-494

Link1

Link2 Link3

Treatment for Non-clear Cell Renal Cell Carcinoma

Makoto Sumitomo

Renal Cell Carcinoma. 2017;319-332

Link1

Papillary Renal Cell Carcinoma and Clear Cell Renal Cell Carcinoma Arising in a Single Kidney

Laura Tait, Pamela Coleman, Chiledum Ahaghotu

BJUI. 2012;

Link1 Link2

Efficacy and Safety of Oral Topotecan and Bevacizumab Combination as Second-Line Treatment for Relapsed Small-Cell Lung Cancer: An Open-Label Multicenter Single-Arm Phase II Study

David R. Spigel, David M. Waterhouse, Steve Lane, Philippe Legenne, Kamal Bhatt

Clinical Lung Cancer. 2013;14(4):356-363

Link1 Link2

A Multicenter Phase II Trial of Axitinib in Patients With Recurrent or Metastatic Non–clear-cell Renal Cell Carcinoma Who Had Failed Prior Treatment With Temsirolimus

Inkeun Park, Se Hoon Lee, Jae Lyun Lee

Clinical Genitourinary Cancer. 2018;16(5):e997-e1002

Link1 Link2

Safety and Efficacy of PF-3512676 for the Treatment of Stage IV Renal Cell Carcinoma: An Open-Label, Multicenter Phase I/II Study

John A. Thompson, Timothy Kuzel, Beverly J. Drucker, Walter J. Urba, Ronald M. Bukowski

Clinical Genitourinary Cancer. 2009;7(3):E58-E65

Link1 Link2

T2 CLEAR CELL RENAL CELL CARCINOMA IS A RARE ENTITY: A STUDY OF 120 CLEAR CELL RENAL CELL CARCINOMAS

STEPHEN M. BONSIB

The Journal of Urology. 2005;174(4):1199-1202

Link1 Link2

An Open-Label, Multicenter, Randomized, Phase II Study of Pazopanib in Combination with Pemetrexed in First-Line Treatment of Patients with Advanced-Stage Non–Small-Cell Lung Cancer

Giorgio V. Scagliotti, Enriqueta Felip, Benjamin Besse, Joachim von Pawel, Anders Mellemgaard, Martin Reck, Lionel Bosquee, Christos Chouaid, Pilar Lianes-Barragán, Elaine M. Paul, Rodrigo Ruiz-Soto, Entisar Sigal, Lone H. Ottesen, Thierry LeChevalier

Journal of Thoracic Oncology. 2013;8(12):1529-1537

Link1 Link2

Reintroducing Pazopanib Reverses the Primary Resistance of Nivolumab in a Patient With Metastatic Clear-cell Renal Cell Carcinoma

Harvey Yu-Li Su

Clinical Genitourinary Cancer. 2018;16(2):114-116

Link1 Link2

Efficacy and safety of sorafenib in combination with gemcitabine in patients with advanced hepatocellular carcinoma: A multicenter, open-label, single-arm phase II study

Vichien Srimuninnimit, Virote Sriuranpong, Suthida Suwanvecho

Asia-Pacific Journal of Clinical Oncology. 2014;10(3):255-260

Link1

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.